Literature DB >> 31227475

Sickle cell disease: a new era.

Shmona Simpson1.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 31227475     DOI: 10.1016/S2352-3026(19)30111-5

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN: 2352-3026            Impact factor:   18.959


× No keyword cloud information.
  9 in total

1.  Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial.

Authors:  Mohammed S Alshahrani; Amal H AlSulaibikh; Mohamed R ElTahan; Sukayna Z AlFaraj; Laila P Asonto; Abdullah A AlMulhim; Murad F AlAbbad; Nisreen Almaghraby; Mohammed A AlJumaan; Thamir O AlJunaid; Moath N Darweesh; Faisal M AlHawaj; Alaa M Mahmoud; Bader K Alossaimi; Shaikhah K Alotaibi; Talal M AlMutairi; Duaa A AlSulaiman PharmD; Dunya Alfaraj; Reem Alhawwas; Lawrence Mbuagbaw; Kim Lewis; Madeleine Verhovsek; Mark Crowther; Gordon Guyatt; Waleed Alhazzani
Journal:  Acad Emerg Med       Date:  2021-09-21       Impact factor: 5.221

2.  Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease.

Authors:  Paul W Buehler; Delaney Swindle; David I Pak; Scott K Ferguson; Susan M Majka; Vijaya Karoor; Radu Moldovan; Chantal Sintas; Jennifer Black; Thomas Gentinetta; Raphael M Buzzi; Florence Vallelian; Andreas Wassmer; Monika Edler; Joseph Bain; Daniel Schu; Kathryn Hassell; Rachelle Nuss; Dominik J Schaer; David C Irwin
Journal:  Free Radic Biol Med       Date:  2021-08-31       Impact factor: 8.101

3.  Time to apply a social determinants of health lens to addressing sickle cell disorders in sub-Saharan Africa.

Authors:  Maria Berghs; Bola Ola; Anna Cronin De Chavez; Bassey Ebenso
Journal:  BMJ Glob Health       Date:  2020-07

4.  Caring for Africa's sickle cell children: will we rise to the challenge?

Authors:  Assaf P Oron; Dennis L Chao; Echezona E Ezeanolue; Loveth N Ezenwa; Frédéric B Piel; Osifo Telison Ojogun; Sophie Uyoga; Thomas N Williams; Obiageli E Nnodu
Journal:  BMC Med       Date:  2020-04-28       Impact factor: 8.775

5.  Murine models of sickle cell disease and beta-thalassemia demonstrate pulmonary hypertension with distinctive features.

Authors:  Paul W Buehler; Delaney Swindle; David I Pak; Mehdi A Fini; Kathryn Hassell; Rachelle Nuss; Rebecca B Wilkerson; Angelo D'Alessandro; David C Irwin
Journal:  Pulm Circ       Date:  2021-11-07       Impact factor: 2.886

6.  Pediatric Sickle Cell Disease in Sudan: Complications and Management.

Authors:  Meysaa Talha; Bashier Osman; Safa Abdalla; Hind Mirghani; Iman Abdoon
Journal:  Anemia       Date:  2022-02-14

7.  Health-Related Quality of Life Among Patients With Sickle Cell Disease in an Adult Hematology Clinic in a Tertiary Hospital in Lagos, Nigeria.

Authors:  Lemchukwu Amaeshi; Olufunto O Kalejaiye; Chibuzor F Ogamba; Folasade Adelekan Popoola; Yusuf A Adelabu; Chibuikem A Ikwuegbuenyi; Ijeoma B Nwankwo; Oluwademilade Adeniran; Michael Imeh; Michael O Kehinde
Journal:  Cureus       Date:  2022-01-18

8.  Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease.

Authors:  Aline Renata Pavan; Juliana Romano Lopes; Carlos Henrique Lima Imperador; Chung Man Chin; Jean Leandro Dos Santos
Journal:  Front Med (Lausanne)       Date:  2022-09-08

Review 9.  Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond.

Authors:  Walufu Ivan Egesa; Gloria Nakalema; William M Waibi; Munanura Turyasiima; Emmanuel Amuje; Gloria Kiconco; Simon Odoch; Patrick Kumbowi Kumbakulu; Said Abdirashid; Daniel Asiimwe
Journal:  Int J Pediatr       Date:  2022-10-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.